CALL - SPRINTER OPEN END - AMGEN | Market Closed - Deutsche Boerse AG 11:20:30 31/05/2024 pm IST | ||
| 9.67 EUR | +1.36% |
|
| Current month | +38.14% | ||
| 1 month | +38.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 9.67 | +1.36% |
| 30/24/30 | 9.54 | +6.35% |
| 29/24/29 | 8.97 | -2.07% |
| 28/24/28 | 9.16 | -8.58% |
| 27/24/27 | 10.02 | +1.62% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 11:20 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV16X5 |
| ISIN | DE000VV16X52 |
| Date issued | 06/05/2022 |
| Strike | 200.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.04 € |
|---|---|
| Lowest since issue | 2.38 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
